IRIDEX (IRIX) Gross Profit Margin: History & Chart

IRIDEX Corporation(IRIX)

Medical - Devices · Mountain View, CA

$0.70+0.01 (+1.46%)

Delayed quote: Oct 6, 2026, 11:28 AM EDT

About IRIDEX Corporation

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.

Mountain View, CA

93 employees

www.iridex.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Patrick Mercer

View full financials

IRIX Gross Margin Metrics

GROSS MARGIN

36.23%

GROSS MARGIN AVG TTM

36.20%

GROSS MARGIN AVG 3Y

38.56%

GROSS MARGIN AVG 5Y

40.44%

GROSS MARGIN AVG 10Y

41.92%

GROSS MARGIN AVG 15Y

43.56%

GROSS MARGIN AVG 20Y

44.13%

CURRENT VS TTM AVG

+0.09%

CURRENT VS 3Y AVG

-6.03%

CURRENT VS 5Y AVG

-10.42%

CURRENT VS 10Y AVG

-13.58%

CURRENT VS 15Y AVG

-16.82%

CURRENT VS 20Y AVG

-17.91%

SECTOR MEDIAN · HEALTHCARE

39.82%

median of 678 covered companies

CURRENT VS SECTOR MEDIAN

-9.02%

vs the sector median at left

NAME	MARKET CAP	GROSS MARGIN	TTM	3Y	5Y
IRIDEX Corporation (IRIX)	$12.12M	36.23%	36.20%	38.56%	40.44%
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$12.23M	18.76%	9.38%	50.69%	33.79%
Biofrontera Inc. (BFRI)vs ›	$11.75M	84.45%	64.39%	56.15%	53.94%
Phio Pharmaceuticals Corp. (PHIO)vs ›	$11.57M	0.00%	0.00%	0.00%	0.00%
Dare Bioscience, Inc. (DARE)vs ›	$12.57M	-137.55%	-73123.88%	-36779.95%	-24519.97%
Lantern Pharma Inc. (LTRN)vs ›	$12.47M	0.00%	0.00%	0.00%	0.00%
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.30M	0.00%	50.00%	25.00%	-4489.78%
Cellectar Biosciences, Inc. (CLRB)vs ›	$13.02M	0.00%	0.00%	0.00%	0.00%
Optimi Health Corp. (OPTH)vs ›	$13.44M	-486.44%	-208.47%	-109.22%	-72.81%
BioVie Inc. (BIVI)vs ›	$11.14M	0.00%	0.00%	0.00%	0.00%

NAME

MARKET CAP

GROSS MARGIN

TTM

IRIDEX Corporation (IRIX)

$12.12M

36.23%

36.20%

38.56%

40.44%

Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›

$12.23M

18.76%

9.38%

50.69%

33.79%

Biofrontera Inc. (BFRI)vs ›

$11.75M

84.45%

64.39%

56.15%

53.94%

Phio Pharmaceuticals Corp. (PHIO)vs ›

$11.57M

0.00%

Dare Bioscience, Inc. (DARE)vs ›

$12.57M

-137.55%

-73123.88%

-36779.95%

-24519.97%

Lantern Pharma Inc. (LTRN)vs ›

$12.47M

0.00%

Kiora Pharmaceuticals, Inc. (KPRX)vs ›

$11.30M

0.00%

50.00%

25.00%

-4489.78%

Cellectar Biosciences, Inc. (CLRB)vs ›

$13.02M

0.00%

Optimi Health Corp. (OPTH)vs ›

$13.44M

-486.44%

-208.47%

-109.22%

-72.81%

BioVie Inc. (BIVI)vs ›

$11.14M

0.00%

Gross Margin FAQ

What is the gross margin for IRIDEX Corporation (IRIX)?

The gross margin for IRIX stock is 36.23%.

Is IRIDEX Corporation's gross margin high or low?

The gross margin of 36.23% is 10% below its 5-year average of 40.44%, around the middle of its 5-year range (32.15%–45.56%).

What is the TTM average gross margin for IRIDEX Corporation (IRIX)?

The TTM average gross margin for IRIX stock is 36.20%.

What is the 3Y average gross margin for IRIDEX Corporation (IRIX)?

The 3Y average gross margin for IRIX stock is 38.56%.

What is the 5Y average gross margin for IRIDEX Corporation (IRIX)?

The 5Y average gross margin for IRIX stock is 40.44%.

What is the 10Y average gross margin for IRIDEX Corporation (IRIX)?

The 10Y average gross margin for IRIX stock is 41.92%.

What is the 15Y average gross margin for IRIDEX Corporation (IRIX)?

The 15Y average gross margin for IRIX stock is 43.56%.

What is the 20Y average gross margin for IRIDEX Corporation (IRIX)?

The 20Y average gross margin for IRIX stock is 44.13%.

DATE	GROSS MARGIN
2026-07-04	34.19%
2026-04-04	40.18%
2026-01-03	38.27%
2025-09-27	32.15%
2025-06-28	33.92%
2025-03-29	42.49%
2024-12-31	44.00%
2024-09-28	37.33%
2024-06-29	40.65%
2024-03-30	37.19%
2023-12-31	38.55%
2023-09-30	43.74%
2023-07-01	41.72%
2023-04-01	43.32%
2022-12-31	43.86%
2022-10-01	44.14%
2022-07-02	45.56%
2022-04-02	44.65%
2021-12-31	39.35%
2021-10-02	43.59%
2021-07-03	45.49%
2021-04-03	41.30%
2020-12-31	45.37%
2020-09-26	41.51%
2020-06-27	38.69%
2020-03-28	43.41%
2019-12-31	41.23%
2019-09-28	40.16%
2019-06-29	43.63%
2019-03-30	40.18%
2018-12-31	41.03%
2018-09-29	40.42%
2018-06-30	41.42%
2018-03-31	41.25%
2017-12-31	21.19%
2017-09-30	40.25%
2017-07-01	44.94%
2017-04-01	42.59%
2016-12-31	44.40%
2016-10-01	43.37%
2016-07-02	48.15%
2016-04-02	44.40%
2015-12-31	45.28%
2015-10-03	49.32%
2015-07-04	46.68%
2015-04-04	50.11%
2014-12-31	50.10%
2014-09-27	50.89%
2014-06-28	50.05%
2014-03-29	48.94%
2013-12-31	48.59%
2013-09-28	49.59%
2013-06-29	48.66%
2013-03-30	47.33%
2012-12-31	47.01%
2012-09-29	49.63%
2012-06-30	48.68%
2012-03-31	48.00%
2011-12-31	357.87%
2011-10-01	45.41%
2011-07-02	45.17%
2011-04-02	46.72%
2010-12-31	48.19%
2010-10-02	48.52%
2010-07-03	45.86%
2010-04-03	48.57%
2009-12-31	45.61%
2009-10-03	49.25%
2009-07-04	45.93%
2009-04-04	47.02%
2008-12-31	37.49%
2008-09-27	41.63%
2008-06-28	41.26%
2008-03-29	41.88%
2007-12-31	44.59%
2007-09-29	45.56%
2007-06-30	43.18%
2007-03-31	41.45%
2006-12-31	55.47%
2006-09-30	52.83%
2006-07-01	52.92%
2006-04-01	48.22%
2005-12-31	48.70%
2005-10-01	53.73%
2005-07-02	48.42%
2005-04-02	45.16%
2004-12-31	48.14%
2004-10-02	42.43%
2004-07-03	46.95%
2004-04-03	43.49%
2003-12-31	47.02%
2003-09-27	43.41%
2003-06-28	41.96%
2003-03-29	44.81%
2002-12-31	45.90%
2002-09-28	44.84%

DATE

GROSS MARGIN

2026-07-04

34.19%

2026-04-04

40.18%

2026-01-03

38.27%

2025-09-27

32.15%

2025-06-28

33.92%

2025-03-29

42.49%

2024-12-31

44.00%

2024-09-28

37.33%

2024-06-29

40.65%

2024-03-30

37.19%

2023-12-31

38.55%

2023-09-30

43.74%

2023-07-01

41.72%

2023-04-01

43.32%

2022-12-31

43.86%

2022-10-01

44.14%

2022-07-02

45.56%

2022-04-02

44.65%

2021-12-31

39.35%

2021-10-02

43.59%

2021-07-03

45.49%

2021-04-03

41.30%

2020-12-31

45.37%

2020-09-26

41.51%

2020-06-27

38.69%

2020-03-28

43.41%

2019-12-31

41.23%

2019-09-28

40.16%

2019-06-29

43.63%

2019-03-30

40.18%

2018-12-31

41.03%

2018-09-29

40.42%

2018-06-30

41.42%

2018-03-31

41.25%

2017-12-31

21.19%

2017-09-30

40.25%

2017-07-01

44.94%

2017-04-01

42.59%

2016-12-31

44.40%

2016-10-01

43.37%

2016-07-02

48.15%

2016-04-02

44.40%

2015-12-31

45.28%

2015-10-03

49.32%

2015-07-04

46.68%

2015-04-04

50.11%

2014-12-31

50.10%

2014-09-27

50.89%

2014-06-28

50.05%

2014-03-29

48.94%

2013-12-31

48.59%

2013-09-28

49.59%

2013-06-29

48.66%

2013-03-30

47.33%

2012-12-31

47.01%

2012-09-29

49.63%

2012-06-30

48.68%

2012-03-31

48.00%

2011-12-31

357.87%

2011-10-01

45.41%

2011-07-02

45.17%

2011-04-02

46.72%

2010-12-31

48.19%

2010-10-02

48.52%

2010-07-03

45.86%

2010-04-03

48.57%

2009-12-31

45.61%

2009-10-03

49.25%

2009-07-04

45.93%

2009-04-04

47.02%

2008-12-31

37.49%

2008-09-27

41.63%

2008-06-28

41.26%

2008-03-29

41.88%

2007-12-31

44.59%

2007-09-29

45.56%

2007-06-30

43.18%

2007-03-31

41.45%

2006-12-31

55.47%

2006-09-30

52.83%

2006-07-01

52.92%

2006-04-01

48.22%

2005-12-31

48.70%

2005-10-01

53.73%

2005-07-02

48.42%

2005-04-02

45.16%

2004-12-31

48.14%

2004-10-02

42.43%

2004-07-03

46.95%

2004-04-03

43.49%

2003-12-31

47.02%

2003-09-27

43.41%

2003-06-28

41.96%

2003-03-29

44.81%

2002-12-31

45.90%

2002-09-28

44.84%

Gross Margin: 36.23%

IRIX Gross Margin

IRIX Average Gross Margin Chart

IRIX Current vs Average Gross Margin Chart

IRIX Gross Margin Metrics

IRIX Competitors' Gross Margin

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin FAQ

IRIX Gross Margin History

Related Metrics